SignalEarnings

$CRL (CHARLES RIVER LABORATORIES I..) — 8-K: CRL Q2 FY26 adj. EPS $3.02 beats consensus by 10.6%.

CRL

$278.26

+1.93%

What changed

Adjusted EPS of $3.02 beat the $2.73 consensus by $0.29 (+10.6%). Revenue was $1,004M, down 2.7% YoY. FY2026 adjusted EPS guidance was set at $11.15–$11.45.

Why it matters

Adjusted EPS of $3.02 beat the $2.73 consensus by $0.29 (+10.6%). Revenue was $1,004M, down 2.7% YoY. FY2026 adjusted EPS guidance was set at $11.15–$11.45.

Sources

sec